PDCD1 and infectious mononucleosis: In addition, since many of the clinical symptoms in infectious mononucleosis are due to an overly exuberant T cell response to EBV-infected B cells, PD-1/CTLA-4 blockade could potentially be more harmful than helpful in such patients.